Contribution of CB1 Blockade to the Management of High-Risk Abdominal Obesity

International Journal of Obesity - United Kingdom
doi 10.1038/sj.ijo.0803278
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Peripheral CB1 Cannabinoid Receptor Blockade Improves Cardiometabolic Risk in Mouse Models of Obesity

Journal of Clinical Investigation
Medicine
2010English

Abdominal Obesity as the Colorectal Adenomas Risk Factor

Zaporozhye Medical Journal
2016English

Contribution of Prefabricated Constructions to Reduce the Risk of Project Management

2019English

Epigenetic Contribution to Obesity

Mammalian Genome
Genetics
2020English

Abdominal Obesity: Causal Factor or Simply a Symptom of Obesity-Related Health Risk

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2014English

Abdominal Obesity and Insulin Resistance in People Exposed to Moderate-To-High Levels of Dioxin

PLoS ONE
Multidisciplinary
2016English

Contribution of Obesity to the Rise in Incidence of Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2012English

Obesity and the Endocannabinoid System: Is There Still a Future for CB1 Antagonists in Obesity?

Current obesity reports
Medicine
2012English

The Contribution of Psychosocial Stress to the Obesity Epidemic: An Evolutionary Approach

Hormone and Metabolic Research
BiochemistryEndocrinologyClinical BiochemistryMedicineMetabolismDiabetes
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy